A House tax-writing subcommittee will examine the tax advantages drug companies get through charitable donations to patient assistance programs, the head of the panel said March 7.
Patient assistance programs offer free or low-cost drugs to certain people who can’t afford their medications. Patient assistance programs are now the industry norm, and their activity has skyrocketed in the past two decades. Pharmaceutical companies are among the biggest donors to these types of programs and are therefore able to get massive tax write-offs through the donations.
Since the debate over drug prices has escalated on Capitol Hill there’s been more attention ...